Vertex Pharmaceuticals (VRTX) Common Equity (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted Common Equity of $20.25 billion for Q2 2026, up 17.9% from $17.18 billion a year earlier and up 4.6% from the prior quarter.
Vertex Pharmaceuticals (VRTX) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Vertex Pharmaceuticals' Common Equity came in at $18.67 billion, up 13.7% from FY2024.
- Annual Common Equity shows a five-year compound annual growth rate of 16.5% (FY2020 to FY2025).
- In prior years, Vertex Pharmaceuticals' Common Equity was $16.41 billion in FY2024 (-6.7%), $17.58 billion in FY2023 (+26.4%), $13.91 billion in FY2022 (+37.7%) and $10.1 billion in FY2021 (+16.3%).
- The Q2 2026 figure stands as the highest quarterly Common Equity in data going back to Q4 2009.
- On a year-over-year basis, Common Equity has increased in each of the last five quarters, with growth averaging 6.6% over the last eight quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was Q4 2022, with growth of 37.7%; the weakest was Q1 2025, with a decline of 11.1%.
- According to Business Quant data, Common Equity for the three prior quarters was $19.36 billion (Q1 2026), $18.67 billion (Q4 2025) and $17.32 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.09 Bn | 1,194.71 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 656.38 Bn | 576.24 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 510.79 Bn | 478.80 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 363.00 Bn | 317.38 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 313.89 Bn | 287.12 Bn | - | - |
| 6 | Astrazeneca | 290.02 Bn | 263.91 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 249.59 Bn | 204.98 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 208.15 Bn | 183.26 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 170.74 Bn | 118.10 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Vertex Pharmaceuticals | 137.20 Bn | 109.19 Bn | 2.91 Bn | 20.91 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 20.91 Bn |
| Jun 30, 2026 | 20.25 Bn |
| Mar 31, 2026 | 19.36 Bn |
| Dec 31, 2025 | 18.67 Bn |
| Sep 30, 2025 | 17.32 Bn |
| Jun 30, 2025 | 17.18 Bn |
| Mar 31, 2025 | 16.50 Bn |
| Dec 31, 2024 | 16.41 Bn |
| Sep 30, 2024 | 15.63 Bn |
| Jun 30, 2024 | 14.77 Bn |
| Mar 31, 2024 | 18.55 Bn |
| Dec 31, 2023 | 17.58 Bn |
| Sep 30, 2023 | 16.51 Bn |
| Jun 30, 2023 | 15.47 Bn |
| Mar 31, 2023 | 14.43 Bn |
| Dec 31, 2022 | 13.91 Bn |
| Sep 30, 2022 | 13.03 Bn |
| Jun 30, 2022 | 11.93 Bn |
| Mar 31, 2022 | 10.91 Bn |
| Dec 31, 2021 | 10.10 Bn |
Vertex Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=VRTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();